Intellia Therapeutics Hits Day High with 23.2% Surge in Stock Price

Intellia Therapeutics, Inc. has experienced significant activity today, with the stock surging by 23.2% on June 15, 2026. The stock reached an intraday high of USD 14.97, reflecting a strong performance compared to the S&P 500, which only gained 1.65% on the same day. Over the past week, Intellia has shown a 10.6% increase, while its monthly performance stands at 9.14%. Impressively, the stock has delivered a remarkable 79.54% return over the past year, significantly outpacing the S&P 500's 26.39% gain. Year-to-date, Intellia has risen by 65.96%, further highlighting its robust market position. Despite its recent successes, the company has faced challenges in long-term growth, with an annual operating profit decline of -203.39% over the last five years. However, it has reported positive results for the last three consecutive quarters, with net sales for the first half of the year reaching USD 38.06 million, a growth of 29.03%. The stock's high institutional holdings at 100% indicate strong backing from investors with substantial resources to analyze the company's fundamentals.